Acadia Pharmaceuticals (ACAD) Share-based Compensation (2010 - 2026)
Acadia Pharmaceuticals' quarterly Share-based Compensation came in at $14.7 million in Q1 2026, up 29.16% year-on-year from $11.4 million in Q1 2025, and up 11.05% quarter-over-quarter from $13.2 million in Q4 2025.
Acadia Pharmaceuticals has reported Share-based Compensation for 17 years, with the latest figure at $14.7 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 29.16% year-over-year to $14.7 million; the trailing twelve-month figure through Mar 2026 stood at $55.5 million (down 12.92% YoY), and the FY2025 full-year result was $52.1 million, down 22.24% from the prior year.
- Share-based Compensation for Q1 2026 stood at $14.7 million, up from $13.2 million in the prior quarter.
- The five-year high for Share-based Compensation was $26.2 million in Q3 2024, with the low at $10.4 million in Q4 2024.
- Average Share-based Compensation over 5 years is $15.8 million, with a median of $14.8 million recorded in 2024.
- Year-over-year, Share-based Compensation soared 41.13% in 2024 and slumped 49.63% in 2025.
- Tracing ACAD's Share-based Compensation over 5 years: stood at $14.4 million in 2022, then advanced by 25.04% to $18.0 million in 2023, then tumbled by 42.02% to $10.4 million in 2024, then grew by 26.65% to $13.2 million in 2025, then grew by 11.05% to $14.7 million in 2026.
- The last three Share-based Compensation figures came in at $14.7 million (Q1 2026), $13.2 million (Q4 2025), and $13.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn | 14.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.70 Mn |
| Mar 31, 2026 | 14.70 Mn |
| Dec 31, 2025 | 13.24 Mn |
| Dec 31, 2025 | 13.24 Mn |
| Sep 30, 2025 | 13.18 Mn |
| Sep 30, 2025 | 13.18 Mn |
| Jun 30, 2025 | 14.34 Mn |
| Jun 30, 2025 | 14.34 Mn |
| Mar 31, 2025 | 11.38 Mn |
| Mar 31, 2025 | 11.38 Mn |
| Dec 31, 2024 | 10.45 Mn |
| Dec 31, 2024 | 10.45 Mn |
| Sep 30, 2024 | 26.16 Mn |
| Sep 30, 2024 | 26.16 Mn |
| Jun 30, 2024 | 15.69 Mn |
| Jun 30, 2024 | 15.69 Mn |
| Mar 31, 2024 | 14.75 Mn |
| Mar 31, 2024 | 14.75 Mn |
| Dec 31, 2023 | 18.02 Mn |
| Dec 31, 2023 | 18.02 Mn |
| Sep 30, 2023 | 18.54 Mn |
| Sep 30, 2023 | 18.54 Mn |
| Jun 30, 2023 | 15.15 Mn |
| Jun 30, 2023 | 15.15 Mn |
| Mar 31, 2023 | 14.71 Mn |
| Mar 31, 2023 | 14.71 Mn |
| Dec 31, 2022 | 14.41 Mn |
| Dec 31, 2022 | 14.41 Mn |
| Sep 30, 2022 | 18.31 Mn |
| Sep 30, 2022 | 18.31 Mn |
| Jun 30, 2022 | 20.51 Mn |
| Jun 30, 2022 | 20.51 Mn |
| Mar 31, 2022 | 14.96 Mn |
| Mar 31, 2022 | 14.96 Mn |
| Dec 31, 2021 | 12.88 Mn |
| Dec 31, 2021 | 12.88 Mn |
| Sep 30, 2021 | 15.55 Mn |
| Sep 30, 2021 | 15.55 Mn |
| Jun 30, 2021 | 22.01 Mn |
| Jun 30, 2021 | 22.01 Mn |
| Mar 31, 2021 | 13.18 Mn |
| Mar 31, 2021 | 13.18 Mn |
| Dec 31, 2020 | 21.20 Mn |
| Dec 31, 2020 | 21.20 Mn |
| Sep 30, 2020 | 21.37 Mn |
| Sep 30, 2020 | 21.37 Mn |
| Jun 30, 2020 | 19.51 Mn |
| Jun 30, 2020 | 19.51 Mn |
| Mar 31, 2020 | 22.35 Mn |
| Mar 31, 2020 | 22.35 Mn |
| Dec 31, 2019 | 19.76 Mn |
| Dec 31, 2019 | 19.76 Mn |
| Sep 30, 2019 | 22.02 Mn |
| Sep 30, 2019 | 22.02 Mn |
| Jun 30, 2019 | 20.42 Mn |
| Jun 30, 2019 | 20.42 Mn |
| Mar 31, 2019 | 19.88 Mn |
| Mar 31, 2019 | 19.88 Mn |
| Dec 31, 2018 | 20.40 Mn |
| Dec 31, 2018 | 20.40 Mn |
| Sep 30, 2018 | 20.17 Mn |
| Sep 30, 2018 | 20.17 Mn |
| Jun 30, 2018 | 20.55 Mn |
| Jun 30, 2018 | 20.55 Mn |
| Mar 31, 2018 | 20.44 Mn |
| Mar 31, 2018 | 20.44 Mn |
| Dec 31, 2017 | 22.02 Mn |
| Dec 31, 2017 | 22.02 Mn |
| Sep 30, 2017 | 19.70 Mn |
| Sep 30, 2017 | 19.70 Mn |
| Jun 30, 2017 | 18.24 Mn |
| Jun 30, 2017 | 18.24 Mn |
| Mar 31, 2017 | 15.57 Mn |
| Mar 31, 2017 | 15.57 Mn |
| Dec 31, 2016 | 15.42 Mn |
| Dec 31, 2016 | 15.42 Mn |
| Sep 30, 2016 | 14.01 Mn |
| Sep 30, 2016 | 14.01 Mn |
| Jun 30, 2016 | 13.88 Mn |
| Jun 30, 2016 | 13.88 Mn |
| Mar 31, 2016 | 11.96 Mn |
| Mar 31, 2016 | 11.96 Mn |
| Dec 31, 2015 | 8.90 Mn |
| Dec 31, 2015 | 8.90 Mn |
| Sep 30, 2015 | 9.27 Mn |
| Sep 30, 2015 | 9.27 Mn |
| Jun 30, 2015 | 7.50 Mn |
| Jun 30, 2015 | 7.50 Mn |
| Mar 31, 2015 | 14.53 Mn |
| Mar 31, 2015 | 14.53 Mn |
| Dec 31, 2014 | 4.65 Mn |
| Dec 31, 2014 | 4.65 Mn |
| Sep 30, 2014 | 1.36 Mn |
| Sep 30, 2014 | 1.36 Mn |
| Jun 30, 2014 | 4.30 Mn |
| Jun 30, 2014 | 4.30 Mn |
| Mar 31, 2014 | 3.16 Mn |
| Mar 31, 2014 | 3.16 Mn |
| Dec 31, 2013 | 2.17 Mn |
| Dec 31, 2013 | 2.17 Mn |
| Sep 30, 2013 | 1.20 Mn |
| Sep 30, 2013 | 1.20 Mn |
| Jun 30, 2013 | 1.10 Mn |
| Jun 30, 2013 | 1.10 Mn |
| Mar 31, 2013 | 582,000.00 |
| Mar 31, 2013 | 582,000.00 |
| Dec 31, 2012 | 551,000.00 |
| Dec 31, 2012 | 551,000.00 |
| Sep 30, 2012 | 488,000.00 |
| Sep 30, 2012 | 488,000.00 |
| Jun 30, 2012 | 478,000.00 |
| Jun 30, 2012 | 478,000.00 |
| Mar 31, 2012 | 413,000.00 |
| Mar 31, 2012 | 413,000.00 |
| Dec 31, 2011 | 408,000.00 |
| Dec 31, 2011 | 408,000.00 |
| Sep 30, 2011 | 401,000.00 |
| Sep 30, 2011 | 401,000.00 |
| Jun 30, 2011 | 413,000.00 |
| Jun 30, 2011 | 413,000.00 |
| Mar 31, 2011 | 375,000.00 |
| Mar 31, 2011 | 375,000.00 |
| Dec 31, 2010 | 336,000.00 |
| Dec 31, 2010 | 336,000.00 |
| Sep 30, 2010 | 133,000.00 |
| Sep 30, 2010 | 133,000.00 |